#2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models

Arresting cell cycle has been one of the most common approaches worldwide in cancer therapy. Specifically, arresting cells in the G2/M phase is a promising therapeutic approach in the battle against lung cancer. In the present study, we demonstrated the anticancer activities and possible mechanism o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wen-Jie, Peng, Wen, Sun, Qian-Qian, Li, Yong-Huai, Chen, Bo, Yu, Luo-Ting, Xu, You-Zhi, Wang, Si-Ying, Zhao, Ying-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841443/
https://www.ncbi.nlm.nih.gov/pubmed/29531821
http://dx.doi.org/10.1038/s41420-018-0032-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841443/
https://www.ncbi.nlm.nih.gov/pubmed/29531821
http://dx.doi.org/10.1038/s41420-018-0032-y

Ejemplares similares